Frank Conway joined Larimar Therapeutics in July 2020 as Vice President and Controller. He brings more than 20 years’ experience as a financial executive in the life sciences and medical device fields. Mr. Conway has served as a Controller, Vice President of Finance, and Chief Financial Officer in entrepreneurial public and private environments, both commercial and pre-revenue. He most recently held the position of Vice President of Finance at TELA Bio and was part of the management team that took the company public. Other prior roles include: Corporate Controller at Orthovita, Inc. which was sold to Stryker; Manager of Financial Reporting and Analysis at Centocor; and Chief Financial Officer at Principia Pharmaceuticals, which was acquired by Human Genome Sciences, Inc. Mr. Conway began his career at Ernst & Young. He is a Certified Public Accountant and received his BS in business administration from Drexel University.
